Cobimetinib

COTELLIC®

Overview

Cobimetinib is a kind of drug called a kinase inhibitor that can work by blocking chemicals in the cancer cell that help it to grow and multiply.

SparkCures ID 251
Developed By Exelixis
Brand Name Cotellic®
Generic Name Cobimetinib
Additional Names Cotellic, GDC-0973, XL-518
Treatment Classifications
  • MEK Inhibitor

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.